BRCA1 and breast cancer: Ingenuity Pathway Analysis (IPA) confirmed that multiple pathways were modulated by Gem, and that ISRIB enhanced Gem-mediated expression of genes implicated in BRCA1's DNA damage response and hereditary breast cancer signaling (Figure 4d).